Abstract
Treating ADHD comorbid with autism spectrum disorder (ASD) could improve morbidity and impairment in individuals with autism; however, lower tolerability to psychotropic medications, used to treat ADHD, has been noted in individuals with ASD. The purpose of this interim analysis of the ongoing six-week trial was to assess the tolerability and efficacy of extended-release liquid methylphenidate hydrochloride (brand name Quillivant) for the treatment of ADHD in adults with high-functioning ASD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of the American Academy of Child & Adolescent Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
